Published in Exp Physiol on May 06, 2004
Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: pathophysiological aspects. Heart Fail Rev (2007) 1.46
Acute beta-adrenergic overload produces myocyte damage through calcium leakage from the ryanodine receptor 2 but spares cardiac stem cells. J Biol Chem (2007) 1.36
Cardiac sympathetic afferent denervation attenuates cardiac remodeling and improves cardiovascular dysfunction in rats with heart failure. Hypertension (2014) 1.03
Plasma cell-free DNA in patients needing mechanical ventilation. Crit Care (2011) 0.96
Cation dyshomeostasis and cardiomyocyte necrosis: the Fleckenstein hypothesis revisited. Eur Heart J (2011) 0.96
Hemodynamic variables and mortality in cardiogenic shock: a retrospective cohort study. Crit Care (2009) 0.90
Temporal responses to intrinsically coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria during aldosteronism. Am J Physiol Heart Circ Physiol (2009) 0.90
Dose-dependent separation of the hypertrophic and myotoxic effects of the beta(2)-adrenergic receptor agonist clenbuterol in rat striated muscles. Muscle Nerve (2006) 0.87
Dose-dependent apoptotic and necrotic myocyte death induced by the beta2-adrenergic receptor agonist, clenbuterol. Muscle Nerve (2005) 0.84
Takotsubo cardiomyopathy in the setting of acute alcohol withdrawal. Hawaii J Med Public Health (2012) 0.83
β-Adrenergic Receptor-Stimulated Cardiac Myocyte Apoptosis: Role of β1 Integrins. J Signal Transduct (2011) 0.83
Cardiac and vascular gene profiles in an animal model of takotsubo cardiomyopathy. Heart Vessels (2010) 0.79
Disturbances in calcium metabolism and cardiomyocyte necrosis: the role of calcitropic hormones. Prog Cardiovasc Dis (2012) 0.79
Calcium and zinc dyshomeostasis during isoproterenol-induced acute stressor state. Am J Physiol Heart Circ Physiol (2010) 0.79
Mechanisms of cell death in canine parvovirus-infected cells provide intuitive insights to developing nanotools for medicine. Int J Nanomedicine (2010) 0.79
Intracellular calcium overloading and oxidative stress in cardiomyocyte necrosis via a mitochondriocentric signal-transducer-effector pathway. Exp Clin Cardiol (2011) 0.78
Relative myotoxic and haemodynamic effects of the beta-agonists fenoterol and clenbuterol measured in conscious unrestrained rats. Exp Physiol (2006) 0.77
Effect of crocin on nitric oxide synthase expression in post-ischemic isolated rat heart. Avicenna J Phytomed (2015) 0.76
Histological evidence for reversible cardiomyocyte changes and serum cardiac troponin T elevation after exercise in rats. Physiol Rep (2016) 0.75
Pharmacological Modulation of Calcium Homeostasis in Familial Dilated Cardiomyopathy: An In Vitro Analysis From an RBM20 Patient-Derived iPSC Model. Clin Transl Sci (2016) 0.75
Thymoquinone protects the heart against isoproterenol-induced myocardial ischemia in mice: A histopathological study. Indian J Pharmacol (2016) 0.75
Coenzyme Q10 prevents oxidative stress and fibrosis in isoprenaline induced cardiac remodeling in aged rats. BMC Pharmacol Toxicol (2017) 0.75
Management of acute osteoporotic vertebral fractures: a nonrandomized trial comparing percutaneous vertebroplasty with conservative therapy. Am J Med (2003) 2.66
Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease. J Am Coll Cardiol (2005) 2.42
Clinical outcomes after acute osteoporotic vertebral fractures: a 2-year non-randomised trial comparing percutaneous vertebroplasty with conservative therapy. Med J Aust (2006) 2.40
SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptor. EMBO J (2003) 2.16
MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. Circ Res (2011) 1.67
Aldosterone induces myocyte apoptosis in the heart and skeletal muscles of rats in vivo. J Mol Cell Cardiol (2005) 1.67
Discrepancy between cardiac and physical functional reserves in stroke. Stroke (2012) 1.47
Is there a diurnal variation in repeated sprint ability on a non-motorised treadmill? Chronobiol Int (2013) 1.44
Resident human cardiac stem cells: role in cardiac cellular homeostasis and potential for myocardial regeneration. Nat Clin Pract Cardiovasc Med (2006) 1.41
Characterization of long-term cultured c-kit+ cardiac stem cells derived from adult rat hearts. Stem Cells Dev (2010) 1.31
Adult c-kit(pos) cardiac stem cells fulfill Koch's postulates as causal agents for cardiac regeneration. Circ Res (2014) 1.25
Proteomic investigation of changes in human vastus lateralis muscle in response to interval-exercise training. Proteomics (2009) 1.11
Yap is a novel regulator of C2C12 myogenesis. Biochem Biophys Res Commun (2010) 1.10
Have recent vertebroplasty trials changed the indications for vertebroplasty? Cardiovasc Intervent Radiol (2010) 1.09
Differential regulation of vascular smooth muscle and endothelial cell proliferation in vitro and in vivo by cAMP/PKA-activated p85alphaPI3K. Am J Physiol Heart Circ Physiol (2009) 1.08
Concise review: heart regeneration and the role of cardiac stem cells. Stem Cells Transl Med (2013) 1.08
Histomorphometric analysis of fracture healing cascade in acute osteoporotic vertebral body fractures. Bone (2006) 1.06
Cardiomyocyte death and the ageing and failing heart. Exp Physiol (2003) 1.06
c-kitpos GATA-4 high rat cardiac stem cells foster adult cardiomyocyte survival through IGF-1 paracrine signalling. PLoS One (2010) 1.03
Cardiosphere-derived cells improve function in the infarcted rat heart for at least 16 weeks--an MRI study. PLoS One (2011) 1.02
Fludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activation. Am J Physiol Heart Circ Physiol (2007) 1.02
A prospective longitudinal evaluation of the benefits of epicardial lead placement for cardiac resynchronization therapy. Europace (2009) 1.02
beta2-Adrenergic receptor stimulation in vivo induces apoptosis in the rat heart and soleus muscle. J Appl Physiol (1985) (2004) 0.98
Myotoxic effects of clenbuterol in the rat heart and soleus muscle. J Appl Physiol (1985) (2002) 0.95
Aging exacerbates negative remodeling and impairs endothelial regeneration after balloon injury. Am J Physiol Heart Circ Physiol (2004) 0.94
Cardiac stem and progenitor cell biology for regenerative medicine. Trends Cardiovasc Med (2005) 0.94
Sustained delivery of insulin-like growth factor-1/hepatocyte growth factor stimulates endogenous cardiac repair in the chronic infarcted pig heart. J Cardiovasc Transl Res (2014) 0.93
MicroRNA-1 downregulation increases connexin 43 displacement and induces ventricular tachyarrhythmias in rodent hypertrophic hearts. PLoS One (2013) 0.89
Growth-factor-mediated cardiac stem cell activation in myocardial regeneration. Nat Clin Pract Cardiovasc Med (2007) 0.88
How do different indicators of cardiac pump function impact upon the long-term prognosis of patients with chronic heart failure? Am Heart J (2005) 0.87
Dose-dependent separation of the hypertrophic and myotoxic effects of the beta(2)-adrenergic receptor agonist clenbuterol in rat striated muscles. Muscle Nerve (2006) 0.87
Angiotensin II induces apoptosis in vivo in skeletal, as well as cardiac, muscle of the rat. Exp Physiol (2005) 0.86
The role of endothelial progenitor and cardiac stem cells in the cardiovascular adaptations to age and exercise. Front Biosci (Landmark Ed) (2009) 0.86
Characterisation of isoprenaline myotoxicity on slow-twitch skeletal versus cardiac muscle. Int J Cardiol (2002) 0.84
Exercise duration and peak systolic blood pressure are predictive of mortality in ambulatory patients with mild-moderate chronic heart failure. Cardiology (2005) 0.84
Cardiac stem cell-based myocardial regeneration: towards a translational approach. Cardiovasc Hematol Agents Med Chem (2008) 0.84
Dose-dependent apoptotic and necrotic myocyte death induced by the beta2-adrenergic receptor agonist, clenbuterol. Muscle Nerve (2005) 0.84
LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: results from the "LOWERING-IT" Trial. Am Heart J (2010) 0.83
Characterization of adrenoceptor involvement in skeletal and cardiac myotoxicity Induced by sympathomimetic agents: toward a new bioassay for beta-blockers. J Cardiovasc Pharmacol (2003) 0.82
Relative toxicity of cardiotonic agents: some induce more cardiac and skeletal myocyte apoptosis and necrosis in vivo than others. Cardiovasc Toxicol (2005) 0.82
Comparison and relation of indirect and direct dynamic indexes of cardiac pumping capacity in chronic heart failure. Am J Cardiol (2005) 0.81
Exercise improves mitochondrial and redox-regulated stress responses in the elderly: better late than never! Biogerontology (2014) 0.81
Carbonic anhydrase activation is associated with worsened pathological remodeling in human ischemic diabetic cardiomyopathy. J Am Heart Assoc (2014) 0.81
Urinary proteomics in obstructive sleep apnoea and obesity. Eur J Clin Invest (2014) 0.80
Correcting data for body size may confound results. Chest (2006) 0.78
Lifelong endurance training attenuates age-related genotoxic stress in human skeletal muscle. Longev Healthspan (2013) 0.78
A study of presbycardia, with gender differences favoring ageing women. Int J Cardiol (2008) 0.78
Microbial cellulose wound dressing in the treatment of nonhealing lower extremity ulcers. Wounds (2009) 0.78
Is plasma N-BNP a good indicator of the functional reserve of failing hearts? The FRESH-BNP study. Eur J Heart Fail (2004) 0.77
Relative myotoxic and haemodynamic effects of the beta-agonists fenoterol and clenbuterol measured in conscious unrestrained rats. Exp Physiol (2006) 0.77
Comparison of plasma N-brain natriuretic peptide, peak oxygen consumption, and left ventricular ejection fraction for severity of chronic heart failure. Am J Cardiol (2004) 0.77
Is uremic cardiomyopathy a direct consequence of chronic kidney disease? Expert Rev Cardiovasc Ther (2014) 0.76
Resident progenitors and bone marrow stem cells in myocardial renewal and repair. Nat Clin Pract Cardiovasc Med (2006) 0.76
200+ years of a misunderstood drug for treating chronic heart failure: digoxin, why and how should we continue using it? Int J Cardiol (2012) 0.76
Vertebroplasty for acute osteoporotic fractures - position statement from the Interventional Radiology Society of Australasia. J Med Imaging Radiat Oncol (2011) 0.76
Testing regeneration of human myocardium without knowing the identity and the number of effective bone marrow cells transplanted: are the results meaningful? J Am Coll Cardiol (2006) 0.76
Peak exercise responses in heart failure: back to basics. Eur Heart J (2009) 0.75
Assessing the effect of ACE inhibitors on exercise tolerance: a question of study design. Eur Heart J (2004) 0.75
Impaired left ventricular function in obesity? Eur Heart J (2005) 0.75
Does lowering evening rectal temperature to morning levels offset the diurnal variation in muscle force production? Chronobiol Int (2013) 0.75
Left ventricular assist devices and drug therapy in heart failure. N Engl J Med (2007) 0.75
VALUE: analysis of results. Lancet (2004) 0.75
Relationship of serum cardiac markers following successful percutaneous coronary intervention and subsequent exercise capacity in patients with chronic stable angina: a pilot study. Cardiology (2004) 0.75
Troponin leak in heart failure: moving forward to arrest cardiomyocyte attrition and promote myocardial regeneration. Int J Cardiol (2012) 0.75
Reduced cardiac functional reserve and quality of life in adults with GH deficiency. Clin Endocrinol (Oxf) (2009) 0.75
Characterisation of isoform-specific tryptic peptides of rat cardiac myosin heavy chains using automated liquid chromatography-matrix assisted laser desorption ionisation (LC-MALDI) mass spectrometry. Int J Cardiol (2008) 0.75
Short-axis 2D strain from speckle tracking predicts echocardiographic response to cardiac resynchronization therapy. Echocardiography (2010) 0.75
Atrial Fibrillation reduces the Functional REServe of the Heart by a fifth: a pilot FRESH-AF study. Int J Cardiol (2013) 0.75
Cardiac functional reserve is diminished in growth hormone-deficient adults. Cardiovasc Ther (2009) 0.75
Cardiac functional benefits of ivabradine therapy in patients with severe heart failure. Int J Cardiol (2012) 0.75
Efficacy of lifestyle intervention on peak exercise cardiac power output and reserve in premenopausal obese females: a randomised pilot study. Int J Cardiol (2007) 0.75
A mechanistic investigation into how long-term resynchronization therapy confers ongoing cardiac functional benefits and improved exercise capacity. Am J Cardiol (2009) 0.75
A parallel open-label trial to evaluate microbial cellulose wound dressing in the treatment of diabetic foot ulcers. Int Wound J (2010) 0.75
New evidence of cardiac dysfunction associated with renal impairment. Int J Cardiol (2011) 0.75
English translation of abstracts of original articles published in German 50 years ago on the discovery of aldosterone. Int J Cardiol (2004) 0.75